Average Co-Inventor Count = 10.01
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Metabolex, Inc. (6 from 41 patents)
2. Cymabay Therapeutics, Inc. (5 from 43 patents)
11 patents:
1. 9925189 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
2. 9737537 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
3. 8975258 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
4. 8921350 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
5. 8846675 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
6. 8598374 - GPR120 receptor agonists and uses thereof
7. 8476308 - GPR120 receptor agonists and uses thereof
8. 8309600 - GPR120 receptor agonists and uses thereof
9. 8299117 - GPR120 receptor agonists and uses thereof
10. 8227495 - 2,4-disubsituted thiazoles and pharmaceutical compositions thereof
11. 8183381 - N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders